[Pubmed] Reply to: Intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations
Posté : 14 avr. 2023 12:00
Expert Opin Pharmacother. 2023 Apr 14. doi: 10.1080/14656566.2023.2203813. Online ahead of print.
NO ABSTRACT
PMID:37057628 | DOI:10.1080/14656566.2023.2203813
Source: https://pubmed.ncbi.nlm.nih.gov/3705762 ... t6+86293ac